|
Re: Top 5 things Apabetalone could correct for our health,...
|
8
|
Resverlogix Corp.
|
Nov 11, 2019 01:38PM
|
|
Re: If BP buys Apabetalone,...
|
7
|
Resverlogix Corp.
|
Nov 06, 2019 12:30PM
|
|
Re: Alzheimer's news
|
6
|
Resverlogix Corp.
|
Nov 04, 2019 04:14PM
|
|
Re: Righting the (underpowered) vessel
|
7
|
Resverlogix Corp.
|
Oct 31, 2019 05:43PM
|
|
Righting the (underpowered) vessel
|
6
|
Resverlogix Corp.
|
Oct 31, 2019 04:51PM
|
|
Re: AGMs
|
4
|
Resverlogix Corp.
|
Oct 31, 2019 03:03PM
|
|
Multiple endpoints
|
4
|
Resverlogix Corp.
|
Oct 31, 2019 01:47PM
|
|
Re: Question to ask at the AGM
|
3
|
Resverlogix Corp.
|
Oct 31, 2019 01:35PM
|
|
Re: ask Don?
|
8
|
Resverlogix Corp.
|
Oct 29, 2019 12:00PM
|
|
Re: Just back from IR,...
|
12
|
Resverlogix Corp.
|
Oct 25, 2019 11:20PM
|
|
Re: I asked IR...
|
9
|
Resverlogix Corp.
|
Oct 24, 2019 05:30PM
|
|
Re: Apabetalone and Alkaline Phosphatase
|
3
|
Resverlogix Corp.
|
Oct 12, 2019 11:36AM
|
|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
4
|
Resverlogix Corp.
|
Oct 03, 2019 12:33PM
|
|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
7
|
Resverlogix Corp.
|
Oct 03, 2019 12:20PM
|
|
Re: EagleEyeCap...
|
9
|
Resverlogix Corp.
|
Oct 02, 2019 02:45PM
|
|
Re: BIO CEO Slides Up
|
2
|
Resverlogix Corp.
|
Sep 18, 2019 07:00PM
|
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 04:27PM
|
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
1
|
Resverlogix Corp.
|
Sep 16, 2019 03:37PM
|
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
1
|
Resverlogix Corp.
|
Sep 16, 2019 02:38PM
|
|
Re: Contest
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 01:32PM
|
